Collaborative Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,676
Closed -$465K 218
2025
Q4
$465K Buy
+18,676
New +$471K 0.16% 118
2023
Q1
Sell
-4,152
Closed -$213K 172
2022
Q4
$213K Buy
+4,152
New +$199K 0.14% 161
2022
Q3
Sell
-4,348
Closed -$228K 183
2022
Q2
$228K Buy
+4,348
New +$222K 0.15% 164
2021
Q4
$349K Buy
+5,904
New +$293K 0.19% 147
2021
Q1
$229K Buy
+4,428
New +$157K 0.13% 174

Other funds holding PFE

Collaborative Wealth Management's PFE Position: Q1 2026 in Review

Collaborative Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 18,676 shares — an estimated $465K sold.

Collaborative Wealth Management first reported a position in PFE in Q1 2021 and held it in 5 quarters. The position peaked at $465K in Q4 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Collaborative Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Collaborative Wealth Management sold 18,676 Pfizer shares in Q1 2026, an estimated $465K.
  • Collaborative Wealth Management first reported a position in Pfizer in Q1 2021 and held it in 5 quarters.
  • Collaborative Wealth Management's Pfizer position peaked at $465K in Q4 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Collaborative Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.